Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Cumberland Pharmaceuticals (CPIX) Assets Average (2016 - 2026)

Cumberland Pharmaceuticals' Assets Average history spans 15 years, with the latest figure at $71.4 million for Q4 2025.

  • On a quarterly basis, Assets Average fell 6.31% to $71.4 million in Q4 2025 year-over-year; TTM through Dec 2025 was $71.4 million, a 6.31% decrease, with the full-year FY2025 number at $76.2 million, down 3.15% from a year prior.
  • Assets Average hit $71.4 million in Q4 2025 for Cumberland Pharmaceuticals, up from $66.9 million in the prior quarter.
  • Over the last five years, Assets Average for CPIX hit a ceiling of $94.9 million in Q1 2021 and a floor of $66.9 million in Q3 2025.
  • Historically, Assets Average has averaged $83.9 million across 5 years, with a median of $87.1 million in 2021.
  • Biggest five-year swings in Assets Average: increased 6.78% in 2022 and later decreased 13.86% in 2025.
  • Tracing CPIX's Assets Average over 5 years: stood at $86.0 million in 2021, then grew by 6.78% to $91.9 million in 2022, then fell by 7.72% to $84.8 million in 2023, then fell by 10.14% to $76.2 million in 2024, then fell by 6.31% to $71.4 million in 2025.
  • Business Quant data shows Assets Average for CPIX at $71.4 million in Q4 2025, $66.9 million in Q3 2025, and $68.9 million in Q2 2025.